- DOJ reaches largest-ever federal government settlement over auto loan discrimination
- U.S. Navy to start giving gay couples marriage benefits in Japan
- Sen. Harry Reid goes to hospital as a precaution
- Fla.’s Trey Radel exits rehab, ‘excited’ to resume congressional role
- U.S. nuclear general boozed it up, chased ‘hot women’ in Russia: report
- 45 Calif. students at one school test positive for tuberculosis exposure
- Rob Ford on women: Give them cash ‘and they are happy’
- Ku Klux Klan group holds recruitment meeting in Maryland
- Airport assassination: Mayor, 3 others killed at Manila airport
- Tea party-type lawmakers take mysterious, off-books trip to Mideast
Justice Dept.: Johnson & Johnson agrees to pay $2.2B
Question of the Day
WASHINGTON (AP) — Johnson & Johnson and its subsidiaries have agreed to pay over $2.2 billion to resolve criminal and civil allegations of promoting three prescription drugs for off-label uses not approved by the Food and Drug Administration, the Department of Justice announced on Monday.
The allegations include paying kickbacks to physicians and pharmacies to recommend and prescribe Risperdal and Invega, both antipsychotic drugs, and Natrecor, which is used to treat heart failure.
The figure includes $1.72 billion in civil settlements with federal and state governments as well as $485 million in criminal fines and forfeited profits.
The agreement is the third-largest U.S. settlement involving a drugmaker, and the latest in a string of legal actions against drug companies allegedly putting profits ahead of patients. In recent years, the government has cracked down on the industry’s aggressive marketing tactics, which include pushing medicines for unapproved uses. While doctors are allowed to prescribe medicines for any use, drugmakers cannot promote them in any way that is not approved by FDA.
Last year British drugmaker GlaxoSmithKline paid a record-setting $3 billion in fines to settle criminal and civil violations involving 10 of its drugs.
By John McAfee
- Huge backlash mounts over suspension of 'Duck Dynasty' star Phil Robertson
- D.C. to tout Obamacare among youth waiting for Air Jordans
- Dems use new filibuster rules to approve DHS nominee Alejandro Mayorkas under investigation
- TARGET credit card theft swells to 40 million victims
- Obamacare 'pajamas boy' gets roundly mocked
- Special ops vets slam military benefit cuts
- Deportations under Obama plunged to just 1 percent last year
- Homeland Security helps smuggle illegal immigrant children into the U.S.
- Citing 'unfair system,' Obama commutes sentences for 8 crack offenders
- EDITORIAL: Red faces at the White House
Independent voices from the The Washington Times Communities
Politics, economics, and business from a real world perspective.
Consummate traveler Todd DeFeo explores the unique stories that make destinations worth going to.
Top 10 handguns in the U.S.
Extraordinary day at Redskins Park
White House pets gone wild!
Let it snow